DUBLIN–(BUSINESS WIRE)–The “Wound Cleanser Market – A Global and Regional Analysis: Focus on Product, Wound Type, End User, and Country Analysis – Analysis and Forecast, 2023-2030” report has been added to ResearchAndMarkets.com’s offering.
The global wound cleanser market, valued at $1.87 Billion in 2022, is projected to surge at a compound annual growth rate (CAGR) of 3.34% between 2023 and 2030, reaching $2.43 Billion.
The market’s growth is driven by several key factors, including the rising prevalence of chronic diseases, an uptick in surgical and trauma cases, increased acceptance of wound cleanser products, a surge in wound infections, and the proliferation of specialty wound care clinics.
Market Introduction
Wound cleansers are vital solutions used to clean and irrigate wounds, playing a pivotal role in wound care management. These products are essential for promoting proper wound healing, preventing infections, and maintaining wound hygiene. Wound cleansers encompass a variety of solutions designed to remove debris, bacteria, and contaminants from wounds, facilitating healing and reducing infection risk.
Market Segmentation
Segmentation 1: by Product
Commercial Cleanser
Saline
Commercial Cleansers to Occupy the Largest Share in the Global Wound Cleanser Market (by Product)
Commercial Cleanser: Specially formulated to cleanse and promote wound healing, commercial cleansers offer diverse formulations tailored to specific wound care needs, efficiently removing debris and contaminants.
Saline: Widely used in wound care, saline solutions provide a gentle, effective means of cleansing and irrigating wounds, closely resembling the body’s natural fluids.
Segmentation 2: by Wound
Chronic Wound
Acute Wound
Acute Wounds to Dominate the Global Wound Cleanser Market (by Wound Type)
Chronic Wound: Complex, slow-healing wounds, often associated with chronic diseases such as diabetes.
Acute Wound: Predictably healing wounds resulting from external injuries, with a defined healing trajectory.
Segmentation 3: by End User
Hospitals
Specialty Clinics
Home Healthcare (Over the Counter – OTC)
Hospitals to Dominate the Global Wound Cleanser Market (by End User)
Hospitals are poised for the highest growth due to factors like an aging population, increased public funding, and cost-effectiveness.
Segmentation 4: by Region
North America
Europe
Asia-Pacific
Latin America
Rest-of-the-World
China led the Asia-Pacific wound cleanser market in 2022, driven by demand for wound recovery products and the rising incidence of chronic wounds, notably among diabetic patients.
Recent Developments in the Wound Cleanser Market
In January 2023, Sonoma Pharmaceuticals, Inc. secured a distribution and pricing agreement for its Microcyn Rx products, allowing distribution through the Defense Logistics Agency.
In November 2022, InfuSystem Holdings, Inc. and Sanara MedTech Inc. formed a partnership for SI Wound Care, LLC, offering innovative wound care solutions.
In June 2023, Armis Biopharma’s VeriCyn Wound Wash received FDA 510(k) clearance for wound cleansing.
In April 2023, Convatec acquired technology from U.K.-based firm 30 Technology.
In February 2023, Shore Capital Partners sold Argentum Medical to BioDerm.
In May 2023, NovaBay Pharmaceuticals, Inc. reported a $1 million purchase of its NeutroPhase Skin and Wound Cleanser by China Pioneer Pharma Holdings, Limited.
In April 2023, Sanara MedTech Inc. gained FDA 510(k) clearance for BIASURGE, an advanced surgical solution.
Demand – Drivers and Limitations
Demand Drivers:
Increase in Prevalence of Chronic Disease Leading to Increased Utilization of Wound Cleansers
Rising Number of Surgical and Trauma Cases
Growing Acceptance and Utilization of Wound Cleanser Products
Rise in Prevalence of Wound Infections
Growing Number of Specialty Wound Care Clinics Creating Demand for Advanced Wound Care Products
Restraints:
Lack of Medical Education and Awareness
Lack of Adequate Reimbursement Policies
Opportunities:
Expansion into Emerging Economies
Key Market Players and Competition Synopsis
Key companies in the wound cleanser market include 3M, ACTO GmbH, Argentum Medical, LLC, B. Braun S.E., Bactiguard AB, Coloplast Group, Cardinal Health, Inc., Gentell, Inc., Hollister Incorporated, Medline Industries, LP, Molnlycke Health Care AB, Schulke & Mayr GmbH, Smith & Nephew, Sonoma Pharmaceuticals, Inc., Sanara Medtech, Inc., and Urgo Medical.
Key Questions Answered in the Report
What are the major market drivers, challenges, and opportunities in the global wound cleanser market?
What are the emerging trends within the global wound cleanser market?
How is each segment of the wound cleanser market expected to grow during the forecast period, and what is the anticipated revenue generated by each of the segments by the end of 2030?
Who are the leading players with significant offerings to the wound cleanser market?
What is the regulatory framework in the global wound cleanser market?
What is the growth potential of the global wound cleanser market in North America, Europe, Asia-Pacific, and Latin America and Rest-of-the-World?
What are the pricing analysis given by the key players in the industry?
What is the supply chain scenario in the global wound cleanser market?
Key Attributes:
Report Attribute
Details
No. of Pages
204
Forecast Period
2023 – 2030
Estimated Market Value (USD) in 2023
$1.93 Billion
Forecasted Market Value (USD) by 2030
$2.43 Billion
Compound Annual Growth Rate
3.3%
Regions Covered
Global
For more information about this report visit https://www.researchandmarkets.com/r/ln5ytn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
